Giulia Maddalena

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center.

Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center.

Journal: JCO precision oncology

Published: August 12, 2026

Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

Journal: Journal for immunotherapy of cancer

Published: August 10, 2026

Response to Zhang.

Response to Zhang.

Journal: Journal of the National Cancer Institute

Published: July 31, 2026

Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Journal: Cancer treatment reviews

Published: May 04, 2026

Zanidatamab versus Trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis.

Zanidatamab versus Trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis.

Journal: The oncologist

Published: April 29, 2026

Squamous Cell Anal Carcinoma: Current Therapeutic Approaches.

Squamous Cell Anal Carcinoma: Current Therapeutic Approaches.

Journal: Clinics and research in hepatology and gastroenterology

Published: March 19, 2026

DNA Methylation in Gastric Cancer and Preneoplastic Lesions: Emerging Insights and Future Directions.

DNA Methylation in Gastric Cancer and Preneoplastic Lesions: Emerging Insights and Future Directions.

Journal: Cancers

Published: February 25, 2026

Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 years.

Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 years.

Journal: ESMO open

Published: February 02, 2026

Prognosis and treatment response stratification according to loss of proofreading (LOP) POLE variants.

Prognosis and treatment response stratification according to loss of proofreading (LOP) POLE variants.

Journal: Journal for immunotherapy of cancer

Published: October 22, 2025

Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab.

Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab.

Journal: Journal of the National Cancer Institute

Published: March 11, 2025

Mutational and co-mutational landscape of early onset colorectal cancer.

Mutational and co-mutational landscape of early onset colorectal cancer.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: January 06, 2025

Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome.

Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome.

Journal: The Journal of pathology

Published: July 16, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026